Xiaonan Wu

Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Comprehensive Analysis of Aberrant m6A RNA Modifications Identifies Prognostic Biomarkers in Non-Small Cell Lung Cancer.

Comprehensive Analysis of Aberrant m6A RNA Modifications Identifies Prognostic Biomarkers in Non-Small Cell Lung Cancer.

Journal: International journal of medical sciences
Published: June 16, 2025

Evaluation of two algorithms measuring homologous recombination deficiency status in prognostic assessment for treatment-naïve non-small cell lung cancer.

Evaluation of two algorithms measuring homologous recombination deficiency status in prognostic assessment for treatment-naïve non-small cell lung cancer.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: April 01, 2025

Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis.

Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: April 10, 2024

Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non-small cell lung cancer patients.

Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non-small cell lung cancer patients.

Journal: Cancer medicine
Published: February 08, 2024

Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer.

Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer.

Journal: Chinese medical journal
Published: May 31, 2023

Global burden and trends of lung cancer incidence and mortality.

Global burden and trends of lung cancer incidence and mortality.

Journal: Chinese medical journal
Published: April 07, 2023

Clinical Observation of Immunotherapy Efficacy and Adverse Effects 
in Chinese Patients with Lung Squamous Cell Carcinoma

Clinical Observation of Immunotherapy Efficacy and Adverse Effects 
in Chinese Patients with Lung Squamous Cell Carcinoma

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: July 28, 2022

TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 Immunotherapy.

TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 Immunotherapy.

Journal: Cancers
Published: June 13, 2022

Sputum cell-free DNA for detection of alterations of multiple driver genes in lung adenocarcinoma.

Sputum cell-free DNA for detection of alterations of multiple driver genes in lung adenocarcinoma.

Journal: Cancer cytopathology
Published: May 26, 2022

Instability Mechanism of Osimertinib in Plasma and a Solving Strategy in the Pharmacokinetics Study.

Instability Mechanism of Osimertinib in Plasma and a Solving Strategy in the Pharmacokinetics Study.

Journal: Frontiers in pharmacology
Published: April 26, 2022

Efficacy and safety of anti-PD-1/PD-L1 in combination with chemotherapy or not as first-line treatment for advanced non-small cell lung cancer: A systematic review and network meta-analysis.

Efficacy and safety of anti-PD-1/PD-L1 in combination with chemotherapy or not as first-line treatment for advanced non-small cell lung cancer: A systematic review and network meta-analysis.

Journal: Thoracic cancer
Published: September 24, 2021

Efficacy and safety of bevacizumab combined with EGFR-TKIs in advanced non-small cell lung cancer: A meta-analysis.

Efficacy and safety of bevacizumab combined with EGFR-TKIs in advanced non-small cell lung cancer: A meta-analysis.

Journal: Thoracic cancer
Published: September 23, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026